Tecogen Inc TGEN Q1 2026 Earnings Narrower Loss Surprises Street as Stock Gains 415 Cytokinetics Q1 2026 Earnings Narrower Loss Beats Estimates as Lead Program Aficamten Advances CGON Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Continues RD Investment Crown Castle Q1 2026 Earnings EPS Misses Estimates by 133 Stock Declines DTM Q1 2026 Earnings EPS Surpasses Expectations by Nearly 10 Stock Edges Lower AnaptysBio Inc ANAB Q1 2026 Earnings Significant EPS Miss Amid Clinical Progress